You are going to a different site than you have been browsing. Click continue to visit site or close to select a site with our global language selector.
Kontrollera att sökord är rättstavade.
Prova med annat sökord.
Prova mer generella sökord.
Technology for healthier lives
We understand that delivering quality diagnostic care with the lowest possible radiation dose is a desired goal. Learn how our Dose Management solutions can help you achieve Dose Leadership.
You've earned her trust. Keep it by being a dose management leader.
Goldseal - Renoverade system
Hospital & Healthcare Solutions
DoseWatch - Dose Management Solution
GE Healthcare’s DoseWatch dose management solution can be the cornerstone of a comprehensive, proactive radiation management program.
Lösningar installerad bas
A new life for your imaging systems. Better performance for you.
Återgå till den globala sidan
Dela denna sida
Calculates coronary flow reverse and provides absolute quantitative results for both global and regional myocardial blood flow.
When it comes to the heart, relative quantitative results aren't enough. Current SPECT MPI studies use the area of highest myocardial activity as a reference point for the rest of the perfusion study. If that reference point is also abnormal, it compromises the accuracy of the entire study. In addition, triple vessel disease (balanced ischemia) and microvascular disease don't always result in an abnormal MPI exam. For years, PET has been a well-established gold standard for MBF exams, but it can be limited by cost and accessibility. Recent advancements in SPECT technology have made it possible to enhance the clinical value of nuclear cardiology.
Alcyone CFR leverages highly-sensitive Alcyone technology in our fully-stationary, solid state DiscoveryTM NM530c and Discovery NM/CT 570 systems. It calculates coronary flow reverse and myocardial blood flow from a dynamic SPECT acquisition. In addition, it provides absolute quantitative results for both global and regional blood flow. With a wider availability of low cost SPECT tracers, previously limited to PET technologies, Alcyone CFR provides a real opportunity to explore the benefits of SPECT.
GROW WITH NUCLEAR CARDIOLOGY